Diminished Expression of P-glycoprotein Using Focused Ultrasound Is Associated With JNK-Dependent Signaling Pathway in Cerebral Blood Vessels

被引:19
作者
Choi, HyoJin [1 ]
Lee, Eun-Hee [1 ]
Han, Mun [1 ]
An, Sang-Hyun [2 ]
Park, Juyoung [1 ]
机构
[1] Daegu Gyeongbuk Med Innovat Fdn, Med Device Dev Ctr, Daegu, South Korea
[2] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Daegu, South Korea
基金
新加坡国家研究基金会;
关键词
blood-brain barrier; focused ultrasound; P-glycoprotein; c-Jun N-terminal kinase signaling; vessel integrity; BRAIN-BARRIER; MULTIDRUG-RESISTANCE; DRUG-DELIVERY; INHIBITION; DISRUPTION; CANCER; PROTEIN; CELLS; GENE;
D O I
10.3389/fnins.2019.01350
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MRI-guided focused ultrasound (MRgFUS) combined with microbubbles (MBs) is a promising technology that can facilitate drug delivery through a temporarily disrupted blood-brain barrier (BBB) and induce the down-regulation of P-glycoprotein (P-gp) expression on the blood vessels. Despite the increasing evidence regarding the down-regulation of P-gp expression after MRgFUS BBB disruption (BBBD), its underlying molecular events remain unclear. The aim of this study was to evaluate the underlying mechanism of FUS BBBD-mediated P-gp down-regulation. While our results showed down-regulation of P-gp at 24 h post-BBBD in transcriptional and translational levels, restoration to the normal expression appeared at different time points for transcriptional (72 h) and translational (120 h) levels. In addition, the signaling molecule, JNK, was significantly activated in the cerebral blood vessels at 24 h post-BBBD. Although P-gp levels were significantly decreased, the expression levels of proteins involved in the integrity of blood vessels, such as Glut1, ZO-1 and occludin, were not decreased at 24 h post-BBBD. Our study suggests that the JNK signaling pathway is involved in the regulation of FUS-induced P-gp expression, without affecting vessel integrity, and a detailed regulatory mechanism can provide the basis for clinical application of FUS to the treatment of neurological disease.
引用
收藏
页数:12
相关论文
共 38 条
[1]   Blood-brain barrier structure and function and the challenges for CNS drug delivery [J].
Abbott, N. Joan .
JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) :437-449
[2]   Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors [J].
Alkins, Ryan ;
Burgess, Alison ;
Ganguly, Milan ;
Francia, Giulio ;
Kerbel, Robert ;
Wels, Winfried S. ;
Hynynen, Kullervo .
CANCER RESEARCH, 2013, 73 (06) :1892-1899
[3]   P-glycoprotein Inhibition for Optimal Drug Delivery [J].
Amin, Md. Lutful .
DRUG TARGET INSIGHTS, 2013, 7 :27-34
[4]   Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles [J].
Aryal, Muna ;
Fischer, Krisztina ;
Gentile, Caroline ;
Gitto, Salvatore ;
Zhang, Yong-Zhi ;
McDannold, Nathan .
PLOS ONE, 2017, 12 (01)
[5]   Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy [J].
Bansal, Tripta ;
Jaggi, Manu ;
Khar, Roop K. ;
Talegaonkar, Sushama .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2009, 12 (01) :46-78
[6]   Focused ultrasound-mediated drug delivery through the blood-brain barrier [J].
Burgess, Alison ;
Shah, Kairavi ;
Hough, Olivia ;
Hynynen, Kullervo .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (05) :477-491
[7]   Inhibition of c-Jun N-terminal kinase prevents blood-brain barrier disruption and normalizes the expression of tight junction proteins clautin-5 and ZO-1 in a rat model of subarachnoid hemorrhage [J].
Chen, Duo ;
Wei, Xiang-tai ;
Guan, Jun-hong ;
Yuan, Jiang-wei ;
Peng, Yu-tao ;
Song, Lei ;
Liu, Yun-hui .
ACTA NEUROCHIRURGICA, 2012, 154 (08) :1469-1476
[8]   Localized Down-regulation of P-glycoprotein by Focused Ultrasound and Microbubbles induced Blood-Brain Barrier Disruption in Rat Brain [J].
Cho, HongSeok ;
Lee, Hwa-Youn ;
Han, Mun ;
Choi, Jong-ryul ;
Ahn, Sanghyun ;
Lee, Taekwan ;
Chang, Yongmin ;
Park, Juyoung .
SCIENTIFIC REPORTS, 2016, 6
[9]   Variable modulation of opioid brain uptake by P-glycoprotein in mice [J].
Dagenais, C ;
Graff, CL ;
Pollack, GM .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (02) :269-276
[10]  
Davis Thomas P, 2014, Adv Pharmacol, V71, P25, DOI 10.1016/bs.apha.2014.06.009